Bone metabolism and gonad function in male patients undergoing liver transplantation: A two-year longitudinal study

Citation
A. Floreani et al., Bone metabolism and gonad function in male patients undergoing liver transplantation: A two-year longitudinal study, OSTEOPOR IN, 12(9), 2001, pp. 749-754
Citations number
29
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
OSTEOPOROSIS INTERNATIONAL
ISSN journal
0937941X → ACNP
Volume
12
Issue
9
Year of publication
2001
Pages
749 - 754
Database
ISI
SICI code
0937-941X(2001)12:9<749:BMAGFI>2.0.ZU;2-T
Abstract
Osteodystrophy is a major complication of end-stage liver disease, especial ly in postmenopausal women. Our aim in this study was to evaluate bone meta bolism and gonad function in men undergoing orthotopic liver transplantatio n (OLTx). Twenty-three consecutive men (mean age 48 +/- 13 years) evaluated for OLTx were studied, assessing the following parameters at baseline and 3, 6, 12 and 24 months after OLTx: lumbar spine (L2-L4) bone mineral densit y (BMD), parathyroid hormone (PTH), osteocalcin (BGP), 25-hydroxyvitamin D (250HD), free testosterone (FT) and gonadotropins (FSH, LH). At baseline, 1 2 patients (52%) had a T-score < -2.5 SD and the mean BMD was 0.806 +/- 0. 11 g/cm(2) (range 0.470-1.045 g/cm(2)). The BMD was lower 3 months after OL Tx and significantly higher 12 and 24 months after OLTx. A significant incr ease in serum BGP was observed at 6, 12 (p < 0.05) and 24 months (p <0.005) after OLTx. The mean serum PTH level was 26.6 +/- 3.1 pg/ml at baseline an d increased significantly at 12 and 24 months (to 49.4 +/- 9.9 and 61.2 +/- 10.1 pg/ml, respectively, p <0.05). 250HD serum levels were low at baselin e and returned to the normal range after 12 and 24 months (baseline, 8.73 /- 1.54 ng/ml; 12 months, 16.4 +/- 2.6 ng/ml, 24 months, 17.67 +/- 3.1 ng/m l; p <0.05). FT was significantly lower at baseline than in a group of 10 h ealthy controls (5.09 +/- 10.99., vs 10.3 +/- 1.1 pg/ml; p <0.0001). After OLTx a significant increase in FT was recorded at 6, 12 (p <0.05) and 24 mo nths (p <0.005). FT was not correlated with BMD, however. After OLTx an inc rease in FSH and LH was observed (but failed to reach statistical significa nce) at 3 and 6 months, followed by a slight reduction at 12 and 24 months. Thus a high proportion of men with end-stage liver disease do have osteopo rosis. After OLTx, an early recovery of gonad function is observed, followe d by an increase in bone mass, which occurs from the sixth month onward.